- Tytuł:
- Comparisons of efficacy between frontline treatment with bortezomib-melphalan-prednisone and lenalidomide-dexamethasone for transplant-ineligible multiple myeloma: a multicenter real-world based registry report, CAREMM-2102 study
- Autorzy:
- Źródło:
- Journal of Cancer Research and Clinical Oncology. 149(13):11907-11918
Czasopismo naukowe